Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …

Iron deficiency anaemia is one of the most common disorders in the world. Also, one third of
inflammatory bowel disease (IBD) patients suffer from recurrent anaemia. Anaemia has …

The European Cancer Anaemia Survey (ECAS) was conducted to prospectively evaluate
the prevalence, incidence and treatment of anaemia (haemoglobin< 12.0 g/dL) in European …

Background Anaemia associated with cancer and cancer therapy is an important clinical
factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant …

The role of maternal anemia in the development of postpartum depression (PPD) is unclear.
PPD is a serious disorder that may negatively affect the physical and emotional health of a …

Cancer and chemotherapy-induced anemia (CIA) is commonly encountered among patients
undergoing active chemotherapy with or without radiation therapy. Its pathogenesis is …

Anemia is a common extraintestinal manifestation of inflammatory bowel disease (IBD) and
is frequently overlooked as a complication. Patients with IBD are commonly found to have …

Erythropoietin (EPO) is the crucial cytokine regulator of red blood-cell production. Since the
discovery of EPO in 1985 and the isolation of its cognate receptor four years later, there has …

The aim of this study was to determine whether iron deficiency anemia (IDA) in young South
African mothers alters mother-infant interactions and the infant's development. The study …

Cancer-related anemia is a cytokine-mediated disorder resulting from complex interactions
between tumor cells and the immune system. Overexpression of certain inflammatory …